Lower-sodium oxybate improves idiopathic hypersomnia symptoms and might be a useful first-line therapy or monotherapy or used in combination with alerting agents, newly published data show.
Treatment with Xywav resulted in clinically meaningful improvement in idiopathic hypersomnia symptoms, including excessive daytime sleepiness, sleep inertia and prolonged sleep duration with